Kestrel Therapeutics

Allston, MA · Founded 2020 · Privately Held (backing)

Developer of oncological drugs designed to treat RAS-driven cancers and bring a new therapy to cancer's frequently mutated oncogenic target. Kestrel Therapeutics is based in Allston, MA and was founded in 2020. Its last reported valuation was $17.7 million in Jan 2022. It has raised $20.7 million across 3 recorded rounds; the latest was a $5 million early-stage round in Jul 2025.

Last reported valuation
$17.7M
Oct 2026
Priced at
—
Total raised
$20.7M
Last round
Early Stage VC
Jul 2025

Who backs Kestrel Therapeutics?

5 investors
InvestorType
Harvard Innovation Launch LabOther
S32Venture capital
Cormorant Asset ManagementVenture capital
Pfizer VenturesOther
Santé Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kestrel Therapeutics investors

5 investors are on record for Kestrel Therapeutics, including Harvard Innovation Launch Lab, S32, Cormorant Asset Management and Pfizer Ventures. The early-stage round in Jul 2025 drew 6 investors.

Free account
More of Kestrel Therapeutics with a free account
  • ·Watch Kestrel Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like Kestrel Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View